_version_ 1783268989165633536
author Tornatore, Laura
Sandomenico, Annamaria
Raimondo, Domenico
Low, Caroline
Rocci, Alberto
Tralau-Stewart, Cathy
Capece, Daria
D’Andrea, Daniel
Bua, Marco
Boyle, Eileen
van Duin, Mark
Zoppoli, Pietro
Jaxa-Chamiec, Albert
Thotakura, Anil K.
Dyson, Julian
Walker, Brian A.
Leonardi, Antonio
Chambery, Angela
Driessen, Christoph
Sonneveld, Pieter
Morgan, Gareth
Palumbo, Antonio
Tramontano, Anna
Rahemtulla, Amin
Ruvo, Menotti
Franzoso, Guido
author_facet Tornatore, Laura
Sandomenico, Annamaria
Raimondo, Domenico
Low, Caroline
Rocci, Alberto
Tralau-Stewart, Cathy
Capece, Daria
D’Andrea, Daniel
Bua, Marco
Boyle, Eileen
van Duin, Mark
Zoppoli, Pietro
Jaxa-Chamiec, Albert
Thotakura, Anil K.
Dyson, Julian
Walker, Brian A.
Leonardi, Antonio
Chambery, Angela
Driessen, Christoph
Sonneveld, Pieter
Morgan, Gareth
Palumbo, Antonio
Tramontano, Anna
Rahemtulla, Amin
Ruvo, Menotti
Franzoso, Guido
author_sort Tornatore, Laura
collection PubMed
description
format Online
Article
Text
id pubmed-5629036
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-56290362017-10-11 Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors Tornatore, Laura Sandomenico, Annamaria Raimondo, Domenico Low, Caroline Rocci, Alberto Tralau-Stewart, Cathy Capece, Daria D’Andrea, Daniel Bua, Marco Boyle, Eileen van Duin, Mark Zoppoli, Pietro Jaxa-Chamiec, Albert Thotakura, Anil K. Dyson, Julian Walker, Brian A. Leonardi, Antonio Chambery, Angela Driessen, Christoph Sonneveld, Pieter Morgan, Gareth Palumbo, Antonio Tramontano, Anna Rahemtulla, Amin Ruvo, Menotti Franzoso, Guido Cancer Cell Article Cell Press 2014-12-08 /pmc/articles/PMC5629036/ /pubmed/28898681 http://dx.doi.org/10.1016/j.ccell.2014.11.021 Text en © 2014 The Authors. Published by Elsevier Inc. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Tornatore, Laura
Sandomenico, Annamaria
Raimondo, Domenico
Low, Caroline
Rocci, Alberto
Tralau-Stewart, Cathy
Capece, Daria
D’Andrea, Daniel
Bua, Marco
Boyle, Eileen
van Duin, Mark
Zoppoli, Pietro
Jaxa-Chamiec, Albert
Thotakura, Anil K.
Dyson, Julian
Walker, Brian A.
Leonardi, Antonio
Chambery, Angela
Driessen, Christoph
Sonneveld, Pieter
Morgan, Gareth
Palumbo, Antonio
Tramontano, Anna
Rahemtulla, Amin
Ruvo, Menotti
Franzoso, Guido
Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
title Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
title_full Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
title_fullStr Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
title_full_unstemmed Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
title_short Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
title_sort cancer-selective targeting of the nf-κb survival pathway with gadd45β/mkk7 inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629036/
https://www.ncbi.nlm.nih.gov/pubmed/28898681
http://dx.doi.org/10.1016/j.ccell.2014.11.021
work_keys_str_mv AT tornatorelaura cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT sandomenicoannamaria cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT raimondodomenico cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT lowcaroline cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT roccialberto cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT tralaustewartcathy cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT capecedaria cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT dandreadaniel cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT buamarco cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT boyleeileen cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT vanduinmark cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT zoppolipietro cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT jaxachamiecalbert cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT thotakuraanilk cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT dysonjulian cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT walkerbriana cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT leonardiantonio cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT chamberyangela cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT driessenchristoph cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT sonneveldpieter cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT morgangareth cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT palumboantonio cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT tramontanoanna cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT rahemtullaamin cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT ruvomenotti cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors
AT franzosoguido cancerselectivetargetingofthenfkbsurvivalpathwaywithgadd45bmkk7inhibitors